Interestingly, using an additional ovarian cancer cell line we observed that inhibition of PP2A using calyculin A resulted in a significant upregulation of phosphorylated TFE3 with unique nuclear retention (Fig. 3G). The gene discussed is TFE3; the disease is ovarian cancer.